Company Filing History:
Years Active: 2021-2022
Title: Innovator Spotlight: Jonathan Enav from Bnei-Brak, IL
Introduction
Jonathan Enav is a prominent inventor based in Bnei-Brak, Israel, recognized for his contributions to the field of pharmaceuticals. With a total of three patents to his name, Enav has made significant strides in the development of solid-state forms of Valbenazine, showcasing his expertise in innovative drug formulations.
Latest Patents
Enav's latest patents focus on the solid-state forms of Valbenazine. The patents include the disclosure of various salts and solid-state forms of Valbenazine, particularly Valbenazine ditosylate. They detail processes for the preparation of these forms, as well as their pharmaceutical compositions and potential uses. Furthermore, Enav explores the processes for preparing Valbenazine and its intermediates, highlighting his comprehensive understanding of the development process for pharmaceutical compounds.
Career Highlights
Throughout his career, Jonathan Enav has contributed to several prestigious companies, including Assia Chemical Industries Ltd. and Novetide Ltd. His work in these organizations has been instrumental in the R&D of new pharmaceutical technologies, enhancing treatment options for various medical conditions.
Collaborations
Enav has collaborated with notable colleagues, including Marina Yarovoy and Khaled Haj Ali. These partnerships have allowed for the exchange of ideas and expertise, fostering a collaborative environment that has driven innovation in his projects.
Conclusion
Jonathan Enav's dedication to advancing pharmaceutical science through his patent work exemplifies the spirit of innovation. With his focus on Valbenazine and its solid-state forms, he continues to contribute valuable insights to the field, demonstrating the importance of inventive thinking in developing effective medications.